首页> 外文期刊>Clinical & developmental immunology. >The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections
【24h】

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections

机译:HLA类Ib分子在免疫相关疾病,肿瘤和感染中的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

HLA-class Ib family include HLA-E, -F, -G, and -H molecules that, in contrast with high polymorphic HLA-class Ia molecules (HLA-A, -B, and -C), display a limited polymorphism, with a small number of alleles encoding limited functional proteins. Similar to HLA-class Ia molecules, HLA-class Ib molecules bind peptides generated from cytosolic antigens and present them to CD8~+ T lymphocytes, but their main function is the regulation of immune responses, both in physiological and pathological conditions. HLA-G, the best characterized HLA-Ib molecule, is expressed on fetal cytotrophoblast cells during pregnancy and abrogates maternal NK cell cytotoxicity against fetal tissues. However, HLA-G is also expressed (or released as soluble molecules) by different cells and tissues in pathological contexts such as tumors, grafted organs, pathogen-infected cells, and inflammatory tissues. HLA-G interacts with specific receptors on T and B lymphocytes, NK cells, neutrophils, and antigen presenting cells, inhibiting their function. HLA-E is virtually expressed by all nucleated cells and binds peptides derived from HLA-class I molecules leader sequence. In physiological conditions, it interacts with CD94/NKG2A inhibitory receptor on NK cells, inhibiting their cytotoxicity against cells displaying normal HLA-class I molecules expression.
机译:HLA类Ib家族包括HLA-E,-F,-G和-H分子,与高多态性HLA类Ia分子(HLA-A,-B和-C)相反,它们显示出有限的多态性,少数等位基因编码功能有限的蛋白质。与HLA Ia类分子相似,HLA Ib类分子结合细胞溶质抗原产生的肽并将其呈递给CD8 + T淋巴细胞,但它们的主要功能是在生理和病理条件下调节免疫应答。 HLA-G是最有特征的HLA-Ib分子,在怀孕期间在胎儿的细胞滋养层细胞上表达,并消除了母体NK细胞对胎儿组织的细胞毒性。但是,HLA-G还可以在病理情况下,例如肿瘤,移植器官,病原体感染的细胞和炎性组织中,由不同的细胞和组织表达(或作为可溶性分子释放)。 HLA-G与T和B淋巴细胞,NK细胞,嗜中性粒细胞和抗原呈递细胞上的特定受体相互作用,从而抑制其功能。 HLA-E实际上在所有有核细胞中表达,并结合源自HLA-I类分子前导序列的肽。在生理条件下,它与NK细胞上的CD94 / NKG2A抑制受体相互作用,从而抑制它们对显示正常HLA-I类分子表达的细胞的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号